Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
2,802,614
-
Shares change
-
+243,600
-
Total reported value, excl. options
-
$1,193,381
-
Value change
-
+$99,486
-
Put/Call ratio
-
6.4%
-
Number of buys
-
11
-
Number of sells
-
-5
-
Price
-
$0.4269
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q3 2024
29 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q3 2024.
IGC Pharma, Inc. - COM NEW (IGC) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,802,614 shares
.
Largest 10 shareholders include BlackRock, Inc. (703,798 shares), VANGUARD GROUP INC (645,166 shares), GEODE CAPITAL MANAGEMENT, LLC (562,969 shares), STATE STREET CORP (165,307 shares), Virtu Financial LLC (123,060 shares), DEARBORN PARTNERS LLC (116,401 shares), FULLCIRCLE WEALTH LLC (103,443 shares), TWO SIGMA SECURITIES, LLC (99,017 shares), NORTHERN TRUST CORP (71,027 shares), and GOLDMAN SACHS GROUP INC (65,541 shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.